Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Participants With Early Stage Relapsing Remitting Multiple Sclerosis (RRMS)
Public ClinicalTrials.gov record NCT03085810. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Single-Arm Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients With Early Stage Relapsing Remitting Multiple Sclerosis
Study identification
- NCT ID
- NCT03085810
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Enrollment
- 1,225 participants
Conditions and interventions
Conditions
Interventions
- Ocrelizumab Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 23, 2017
- Primary completion
- Apr 26, 2023
- Completion
- Apr 26, 2023
- Last update posted
- Jan 14, 2025
2017 – 2023
United States locations
- U.S. sites
- 26
- U.S. states
- 20
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California Irvine | Irvine | California | 92697 | — |
| Palo Alto Medical Foundation Research Center | Sunnyvale | California | 94086 | — |
| University of Colorado Denver | Aurora | Colorado | 80045 | — |
| Advanced Neurology of Colorado, LLC | Fort Collins | Colorado | 80528 | — |
| KI Health Partners, LLC; New England Institute for Clinical Research | Stamford | Connecticut | 06905 | — |
| Georgetown University Medical Center | Washington D.C. | District of Columbia | 20007 | — |
| University of South Florida - Bradenton | Tampa | Florida | 33612 | — |
| Shepherd Center Inc. | Atlanta | Georgia | 30309 | — |
| College Park Family Care Ctr | Overland Park | Kansas | 66212 | — |
| The NeuroMedical Center | Baton Rouge | Louisiana | 70810 | — |
| Maine Medical Center | Scarborough | Maine | 04074 | — |
| University of Maryland Medical Center; Department of Neurology | Baltimore | Maryland | 21201 | — |
| Neurology Center of New England | Foxborough | Massachusetts | 02035 | — |
| Dragonfly Research, LLC | Wellesley | Massachusetts | 02481 | — |
| Minneapolis Clinic of Neurology | Golden Valley | Minnesota | 55422 | — |
| Cleveland Clinic Lou Ruvo; Center for Brain Research | Las Vegas | Nevada | 89106 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Island Neurological Associates, P.C. | Plainview | New York | 11803 | — |
| Neurology Associates PA | Hickory | North Carolina | 28602 | — |
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27157 | — |
| Cleveland Clinic Foundation; Cleveland Clinic Cancer Center/I40 | Cleveland | Ohio | 44195 | — |
| Neurology Specialists, Inc | Dayton | Ohio | 45417 | — |
| Vanderbilt University Medical Center | Nashville | Tennessee | 37212 | — |
| Kane Hall Barry Neurology | Bedford | Texas | 76021 | — |
| MultiCare Health System Institute for Research and Innovation | Tacoma | Washington | 98405 | — |
| Wheaton Franciscan Healthcare - St. Francis Outpatient Center; Center for Neurological Disorders | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 167 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03085810, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 14, 2025 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03085810 live on ClinicalTrials.gov.